Endocrine & hormone · target hub

INHBC

Inhibin beta C chain (INHBC)

INHBC is a Reproductive / lactation axis on the endocrine & hormone axis. Inhibins and activins inhibit and activate, respectively, the secretion of follitropin by the pituitary gland. Inhibins/activins are involved in regulating a number of diverse functions such as hypothalamic and pituitary hormone secretion, gonadal hormone secretion, germ cell dev… It is indexed under "Reproductive axis (hormones & membrane receptors, selected)" on our pathway page for antibodies, inhibitors, and assay guidance.

Back to pathway overviewSearch: INHBCUniProt (P55103)

Research notes

  • Combine with other genes in the same hub block via genetics or pharmacology to test non-redundant roles of INHBC.
  • For nuclear receptors pair ligands, co-regulators, and reporter assays; for membrane receptors note GPCR/RTK downstream and desensitization.
  • Verify antibody clone, phospho-site, and stimulation; include KD/KO or inhibitor controls.

On the pathway hub (sections)

Genetic lesions & expression context (quick reference)

Type / exampleDomain / context (brief)
Expression contextTissue/cell-type–dependent expression
Rare variantsSporadic variants—require functional validation
Pathway couplingCo-occurs with neighboring nodes on the hub

Naming and prevalence vary by cohort and assay—annotate clinically with COSMIC, ClinVar, OncoKB, and datasheets; research context only.

Assay readouts for INHBC

  • Reproductive axis: INHBC with gonadal steroids, folliculogenesis, or lactation markers.
  • Mammary epithelium: prolactin/progesterone receptor programs.
  • Placenta/trophoblast: BeWo/JEG-3 hormone responses.
  • Sex dimorphism: male vs female tissue expression.

INHBC experimental notes

Examples below reflect common literature and public resources (e.g., CCLE, DepMap)—validate genotypes, expression, and passage in your own stocks before committing assays.

[1] Cell lines commonly used for INHBC studies (examples)

  • Tool lines: BeWo, JEG-3, MCF-7, HEK293T, MEFs—screen by INHBC expression and pathway context (CCLE/DepMap).
  • Combine with neighbors (INHA, INHBA, INHBB, AMH) via KD/pharmacology to test non-redundancy.
  • Overexpression/rescue in HEK293T supports mechanism and IP workflows.
  • Isogenic/CRISPR models separate pathway dependency from bypass survival.

[2] Cell samples for INHBC Western blot

  • Whole-cell lysates—optimize RIPA/NP-40 per antibody; phosphatase inhibitors for phospho blots.
  • Stimulation: serum starvation ± insulin/EGF or amino-acid withdrawal/refeed as relevant.
  • Controls: siRNA/shRNA, CRISPR KO, or inhibitors to validate band specificity.
  • Loading: BCA normalization; subcellular fractionation when needed.

[3] Tissue samples for INHBC Western blot

  • Matched tumor/adjacent frozen tissues after pathology review.
  • Mouse GEMM or xenografts—mind species antibody cross-reactivity.
  • Primary cells/PDCs when ethically approved.
  • FFPE needs specialized extraction; frozen tissue preferred for phospho work.

[4] Cell samples for INHBC immunoprecipitation

  • Tagged overexpression: HEK293T FLAG/HA-INHBC for complex capture.
  • Endogenous IP: high-expression lines; often ≥1–5×10⁶ cells per IP.
  • Stimulation: ligand or nutrient treatments enrich interactions—pilot time courses.
  • Controls: isotype IgG, empty vector, KD/KO negatives.

Human tissues and primary cells require ethics/IRB approval; tumors are heterogeneous—record histotype, site, and preservation conditions.

Bypass & related pathways

Models & genetics note

Overexpression vs endogenous INHBC can differ in dosage, splicing, and compartmentation—in organoids/PDX, record passage, matrix, and drug history.

Quick search presets

INHBCINHBC antibodyINHBC ligand/agonisthormone/receptor antibody

INHBC-related antibodies (keyword-biased)

Adds INHBC keyword bias atop the 内分泌和激素 antibody pool—if sparse, use presets above or global search.

Neighboring targets (same hub)

INHAINHBAINHBBAMHAMHR2BMP15GDF9ESR1

External databases & resources

FAQ

This content supports research reagents and pathway education—not medical advice. Annotate mutations, drug indications, and protocols with authoritative databases, datasheets, and institutional oversight.

Last reviewed: 2026-05-18

Related on this site

See the endocrine & hormone hub for neighboring targets—cross-check PI3K, MAPK, RTK, and metabolism pages as needed.

Endocrine & hormone·PI3K/Akt/mTOR·MAPK/ERK·Receptor tyrosine kinase·Metabolism